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anism on the incidence and outcome of coronary dissection is unknown.
We analyzed 2293 lesions from the Heart Technology Multi-Center Registry
treated with RA to determine predictive factors for and outcomes following
coronary dissections. The incidence of dissection was 8%. Of the dissected
vessels, 22% showed evidence of persistent dye staining. There were no
differences in age (mean, 63yr) and gender (70% male) between the dissec-
tion and non-dissection groups. The incidence of hypertension, diabetes, hy-
percholesterolemia and smoking was not increased in patients with dissec-
tions. The frequency of prior MI, prior CABG and unstable symptoms was not
greater in patients with dissection. Patients with dissections were more likely
to have calcified lesions (57% vs 49%; p = 0.01), tortuous vessels (36% vs
23%; P < 0.001), AHA/ACC type C lesions (29% vs 18%; p = 0.0001) and
primary (79% vs 67%: p < 0.001) rather than restenotic lesions compared to
patients without dissection. Maximal burr size did not differ between the dis-
section and non-dissection groups. Following dissection, 15% of vessels had
sub-TIMIIII flow. Adjunctive PTCA increased the TIMIIiI flow rate to 94%. The
occurrence of dissection was associated with a greater residual stenosis fol-
lowing RA when compared to vessels without dissection (43% vs 38%) but
that difference was negated following adjunctive PTCA (23% vs 20%). Nev-
ertheless, the procedural success rate «50% residual stenosis without ma-
jor complications) was reduced in the presence of dissection (86% vs 96%;
p < 0.001) primarily because patients with dissection more frequently re-
quired CABG than those without dissection (6.4% vs 1.9%; P < 0.001). The
incidence of in-laboratory closure, out-of-Iaboratory closure, coronary pelio-
ration, Q-wave MI, non-Q MI and death were not increased in patients with
dissection.
ConclUSion: Coronary dissection is an uncommon complication of RA that
shares many predictors with PTCA but may have a more benign outcome.
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Thus, PB and Swere equally successful forthe treatment of acute or threat-
ened closure, with no significant difference in 3-month event-free survival.
S reclosure resulted in significantly higher mortality and costs due to longer
hospitalization, more repeat angiography and PTCA.
Ebo D. de Muinck, Peter den HeiJer, Hans-Otto Peels, Ad van Boven, Hans
L. Hillege. University Hospital, Groningen, The Netherlands
Treatment of acute or threatened closure during PTCA with a Stack perfusion
balloon (PB) or Palmaz-Schatz stent (S) was compared regarding: success
(stenosis < 50%, TI.M.1. 3 flow and no in-hospital reclosure or restenosis),
3-rnonth event-free survival, and cost of the intervention based on the total
duration of hospitalization, and the number of repeat interventions in hospi-
tal and during 3-month follow-up. During 3674 PTCA procedures 75 patients
were treated with a PB and 44 received a S for acute or threatened closure.
There were no statistically significant differences regarding: baseline clinical
characteristics, lesion morphology pre-PTCA and lesion morphology before
PB or S. Costs are: 500 US Dollars for 1 day in hospital. 400 for coronary an-
giography, 4790 for PTCA, 9160 for bypass surgery. Five patients died after S,
1 after PB (P < 0.05). In-hospital reclosure occurred 16 times in 12 patients
after S and in 1 patient after PB (P < 0.0002). The PB was successful in 54
(72%) patients and the S in 29 (66%) (P n.s.) There was no difference in 3-
month event-free survival.
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Stenting for Progressive Dissection During PTCA:
Clinical, Angiographic and Intravascular Ultrasound
Criteria to Define a Low-risk Group not ReqUiring
Subsequent Anticoagulation
Helmut Schuhlen, Rudolf Blaslni, Harald Mudra 1, Volker Klauss 1, Adnan Kastrati,
Eva Zitzmann, Petra Neller, Evelyn Regar, Ralph Paloncy, Albert Schomig.
Medizinische Klinik, Technische Universitat Miinchen Germany; 1 Medizinische Klimk
Innenstadt, Ludwig-Maximilians-UniversitBt MtJnchen, Germany
Days in hospital (median:range)
Repeat angiogram
Repeat PTCA (nj
Bypass surgery (n)
Cost Imedian;range)
Data from our previous experience with stenting suggest a subgroup of pa-
tients with a low risk for subacute occlusion of the stented vessel. Within
a six month study period, stents were implanted for progressive dissection
in 141 patients. These patients were screened for the following risk crite-
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Conclusion: Prior angioplastyof a target lesion (restenosis) is protective for
angiographic complications with new devices. Intralesional thrombus in the
setting of unstable angina or saphenous vein grafts confers an increased risk
of angiographic complications. These angiographic complications, in turn,
are predictive of major complications including nonfatal MI, emergency by-
pass surgery, and death.
Late Complications:
(out-ai-hospital death/
MI/CABG or repeat PTCA,
mean follow-up time =
8.8 ± 3.4 months)
S. Chiu Wong, Ya Chien Chuang, Richard A. Schatz, Donald S. Baim,
Sheldon Goldberg, Michael W. Cleman, Jeffrey A. Brinker, Steven R. Bailey, Martin
B. Leon. Washington Hospital Center. Washington, DC
Although well established biologic, anatomic, and angiographic predictors of
adverse clinical events are known for PTCA, there are a paucity of data af-
ter stent (S) implantation. Therefore we compared independent predictors
for adverse clinical events (procedural failure, restenosis, and late complica-
tions) after S (N = 205) vs PTCA (N = 202) treatment from the randomized
multicenter ~ent Restenosis ~tudy (STRESS) by performing multivariate lo-
gistic analysis.
were performed on 596 lesions in 561 patients including excimer laser angio-
plasty (n = 125), rotablator atherectomy (n = 111), and transluminal extrac-
tion atherectomy (n = 330) followed by adjunctive PTCA in 84% of lesions.
Final procedural success was achieved in 86%. Serious angiographic com-
plications (sidebranch occlusion, distal embolization, no reflow, abrupt clo-
sure, perforation) occurred in 9.4% of procedures after the new device and
persisting in 3.2% after adjunctive PTCA. Major complications (non-Q-wave
infarction, Q-wave infarction, emergency bypass surgery, death) occurred in
9.1 % of patients. Multiple logistic regression was performed on all clinical
and angiographic variables to identify independent predictors of serious an-
giographic and clinical complications:
In S pts, final minimal lumen diameter(MLD) strongly influenced procedure
failure, angiographic restenosis, and late complications. In PTCA pts, post-
PTCA dissection predicted procedural failure; diabetes, reference size, and
LAD predicted restenosis: there were no predictors of late complications.
In conclusion: The multivariate analysis of STRESS pt outcomes indicates
1) predictors for adverse clinical events were different for Sand PTCA, 2) S
neutralized the deleterious impact of biologic and anatomic factors on angio-
graphic restenosis and 3)final MLD after S placement, an operator-controlled
variable, strikingly predicted all adverse clinical outcomes. Therefore, metic-
ulous operator attention to optimize final MLD after S placement with appro-
priate adjunct PTCA may further improve clinical outcomes.
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Predictors for Adverse Clinical Events are Different in
Stents and PTCA: Results from the STent REStenosis
Study
David L. Brown, Frank Giordano, Maurice Buchbinder. University of California, San
Diego Medical Center. San Diego, CA
Rotational atherectomy (RA) employs a novel methodology to debulk coro-
nary lesions. Ratherthan improving lumen dimension by stretching and split-
ting the artery as with balloon angioplasty (PTCA), RA differentially abrades
the less compliant atherosclerotic lesion. The effect of this unique mech-
1720-41 Coronary Dissection Following Rotational
Atherectomy: Clinical Characteristics, Angiographic
Predictors and Acute Outcomes
